Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey.

Apple FS, Steffen LM, Pearce LA, Murakami MM, Luepker RV.

Clin Chem. 2012 May;58(5):930-5. doi: 10.1373/clinchem.2011.179176. Epub 2012 Mar 19.

3.

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.

JAMA. 2005 Apr 6;293(13):1609-16.

PMID:
15811980
4.

Predictors of 10-year changes in levels of N-terminal pro B-type natriuretic peptide and cardiac troponin I in the elderly.

Eggers KM, Lindahl B, Venge P, Lind L.

Int J Cardiol. 2018 Apr 15;257:300-305. doi: 10.1016/j.ijcard.2017.10.095.

PMID:
29506712
5.

Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.

Shafi T, Zager PG, Sozio SM, Grams ME, Jaar BG, Christenson RH, Boulware LE, Parekh RS, Powe NR, Coresh J.

Am J Kidney Dis. 2014 Sep;64(3):443-51. doi: 10.1053/j.ajkd.2014.03.015. Epub 2014 Apr 29.

6.

Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.

Hamaya R, Yonetsu T, Kanaji Y, Usui E, Hoshino M, Hada M, Kanno Y, Murai T, Lee T, Kakuta T.

Heart Vessels. 2019 Mar;34(3):410-418. doi: 10.1007/s00380-018-1260-z. Epub 2018 Sep 18.

PMID:
30229410
7.

Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention.

Leistner DM, Klotsche J, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM; DETECT Study Group.

Clin Chem. 2012 Jan;58(1):200-8. doi: 10.1373/clinchem.2011.174292. Epub 2011 Dec 7.

8.

Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study.

Dallmeier D, Denkinger M, Peter R, Rapp K, Jaffe AS, Koenig W, Rothenbacher D; ActiFE Study Group.

Clin Chem. 2015 Feb;61(2):389-99. doi: 10.1373/clinchem.2014.230839. Epub 2014 Dec 10.

9.

N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.

Cheng H, Fan WZ, Wang SC, Liu ZH, Zang HL, Wang LZ, Liu HJ, Shen XH, Liang SQ.

J Crit Care. 2015 Jun;30(3):654.e9-14. doi: 10.1016/j.jcrc.2014.12.008. Epub 2014 Dec 18.

PMID:
25575850
10.

Biomarkers of cardiovascular injury and stress are associated with increased frequency of ventricular ectopy: a population-based study.

Skranes JB, Einvik G, Namtvedt SK, Randby A, Hrubos-Strøm H, Brynildsen J, Hagve TA, Somers VK, Røsjø H, Omland T.

BMC Cardiovasc Disord. 2016 Nov 22;16(1):233.

11.

Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.

Tsutamoto T, Kawahara C, Nishiyama K, Yamaji M, Fujii M, Yamamoto T, Horie M.

Am Heart J. 2010 Jan;159(1):63-7. doi: 10.1016/j.ahj.2009.10.022.

PMID:
20102868
12.

Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.

Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.

Coron Artery Dis. 2009 May;20(3):219-24. doi: 10.1097/MCA.0b013e3283219e47.

PMID:
19322079
13.

High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study.

Tynkkynen J, Hernesniemi JA, Laatikainen T, Havulinna AS, Salo P, Blankenberg S, Zeller T, Salomaa V.

J Neurol. 2017 Mar;264(3):503-511. doi: 10.1007/s00415-016-8378-7. Epub 2016 Dec 30.

PMID:
28039523
14.

Troponin T, B-type natriuretic peptide, C-reactive protein, and cause-specific mortality.

Oluleye OW, Folsom AR, Nambi V, Lutsey PL, Ballantyne CM; ARIC Study Investigators.

Ann Epidemiol. 2013 Feb;23(2):66-73. doi: 10.1016/j.annepidem.2012.11.004. Epub 2012 Dec 8.

15.

Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.

Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg S, Galan P.

Atherosclerosis. 2013 Jun;228(2):478-84. doi: 10.1016/j.atherosclerosis.2013.03.017. Epub 2013 Mar 26.

PMID:
23582589
16.

Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.

Pareek M, Bhatt DL, Vaduganathan M, Biering-Sørensen T, Qamar A, Diederichsen AC, Møller JE, Hindersson P, Leósdóttir M, Magnusson M, Nilsson PM, Olsen MH.

Eur J Prev Cardiol. 2017 Oct;24(15):1648-1659. doi: 10.1177/2047487317717065. Epub 2017 Jun 23.

PMID:
28644092
17.

Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.

Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T.

Am Heart J. 2013 May;165(5):716-24. doi: 10.1016/j.ahj.2013.02.008. Epub 2013 Mar 26.

PMID:
23622908
18.

The relative and combined ability of high-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide to predict cardiovascular events and death in patients with type 2 diabetes.

Hillis GS, Welsh P, Chalmers J, Perkovic V, Chow CK, Li Q, Jun M, Neal B, Zoungas S, Poulter N, Mancia G, Williams B, Sattar N, Woodward M.

Diabetes Care. 2014;37(1):295-303. doi: 10.2337/dc13-1165. Epub 2013 Oct 2. Erratum in: Diabetes Care. 2015 Jul;38(7):1393.

19.

The prognostic value of left ventricular systolic function and cardiac biomarkers in pediatric severe sepsis.

Li J, Ning B, Wang Y, Li B, Qian J, Ren H, Zhang J, Hu X.

Medicine (Baltimore). 2019 Mar;98(13):e15070. doi: 10.1097/MD.0000000000015070.

20.

High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.

Harutyunyan MJ, Mathiasen AB, Winkel P, Gøtze JP, Hansen JF, Hildebrandt P, Jensen GB, Hilden J, Jespersen CM, Kjøller E, Kolmos HJ, Gluud C, Kastrup J; CLARICOR Trial Group.

Scand J Clin Lab Invest. 2011 Feb;71(1):52-62. doi: 10.3109/00365513.2010.538081. Epub 2010 Nov 25.

PMID:
21108561

Supplemental Content

Support Center